2
2perfectboys
Guest
I could see where pulmozyme may be better to use after vest. There are a few problems with this cited trial. Short duration, 2 weeks, and small sample size, only 52 subjects, which the reserchers acknowledged. They also stated "As a finding in a post hoc analysis, the result warrants additional investigation before it could be recommended as a therapeutic directive. " Prehaps there is a nother study that has since looked at this hypothesis or will in the near future.